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Purpose: Sex-associated differences have been identified in the anatomy, physiology and pathophysiology of the human
cornea. We hypothesize that many of these differences are due to fundamental variations in gene expression. Our objective
in this study was to determine whether such differences exist in human corneal epithelial cells both in vivo and in
vitro.Methods: Human corneal epithelial cells were isolated from the corneoscleral rims of male and female donors. Cells
were processed either directly for RNA extraction, or first cultured in phenol red-free keratinocyte serum-free media. The
RNA samples were examined for differentially expressed mRNAs by using of CodeLink Bioarrays and Affymetrix
GeneChips. Data were analyzed with GeneSifter.Net software.Results: Our results demonstrate that sex significantly
influences the expression of over 600 genes in human corneal epithelial cells in vivo. These genes are involved in a broad
spectrum of biological processes, molecular functions and cellular components, such as metabolic processes, DNA
replication, cell migration, RNA binding, oxidoreductase activity and nucleoli. We also identified significant, sex-related
effects on gene expression in human corneal epithelial cells in vitro. However, with few exceptions (e.g. X- and Y-linked
genes), these sex-related differences in gene expression in vitro were typically different than those in vivo.Conclusions:
Our findings support our hypothesis that sex-related differences exist in the gene expression of human corneal epithelial
cells. Variations in gene expression may contribute to sex-related differences in the prevalence of certain corneal diseases.
For almost five decades it has been recognized that sex
exerts a significant influence on the anatomy, physiology and
pathophysiology  of  the  cornea.  Thus,  investigators  have
identified significant, sex-related differences in the diameter,
curvature,  thickness,  sensitivity  and  wetting  time  of  the
cornea, the mitotic rate of corneal epithelial cells, the density
of corneal endothelial cells, as well as the survival rate of
corneal  grafts  [1-15].  Researchers  have  also  reported
significant,  sex-associated  variations  in  the  prevalence  of
Salzmann's  nodular  corneal  degeneration,  against-the-rule
astigmatism,  keratoconus,  viral  keratopathy,  pseudophakic
bullous keratopathy, aphakic bullous keratopathy, interstitial
keratitis, and Fuchs' dystrophy [14,16,17], as well as in the
response to LASIK surgery [18].
In  addition  to  these  observations,  scientists  have
discovered that sex-specific differences in the cornea may also
occur during the menstrual cycle, pregnancy and menopause.
These alterations include changes in the thickness, hydration,
curvature and sensitivity of the cornea, incidence of central
corneal  endothelial  pigmentation,  foreign  body  sensation,
contact lens tolerance and visual acuity [19-30].
We hypothesize that many of these differences are due to
fundamental, sex-associated variations in gene expression.
Our objective in this study was to determine whether such
differences exist in human corneal epithelial cells both in vivo
and in vitro.
Correspondence  to:  David  A.  Sullivan,  Ph.D.,  Schepens  Eye
Research Institute, 20 Staniford Street, Boston, MA, 02114; Phone:
(617)  912-0287;  FAX:  (617)  912-0101;  email:
david.sullivan@schepens.harvard.edu
METHODS
Human  corneal  epithelial  cell  isolation  and  culture
procedures: Corneal epithelial cells were isolated from the
corneoscleral  rims  of  human  donors.  These  tissues  were
obtained  from  the  National  Disease  Research  Interchange
(NDRI; Philadelphia, PA), as well as from physicians at the
Massachusetts Eye & Ear Infirmary (MEEI) after corneal
transplant surgery. All tissues were de-identified prior to our
use,  according  to  Health  Insurance  Portability  and
Accountability Act of 1996 (HIPAA) regulations. Corneal
epithelial  cells  were  either  processed  directly  for  RNA
extraction, or first cultured in vitro. For direct processing,
epithelial cells were scraped off the rims of male (n=3; 34, 44,
and 52 years old) and female (n=3; 31, 44, and 50 years old)
donors  with  a  crescent  knife,  collected  into  TRIzol
(Invitrogen, Carlsbad, CA) and stored at -80 °C until RNA
extraction.
For cell culture, the rims (n=2/sex; males=56 and 60 years
old;  females=42  and  53  years  old)  were  rinsed  with
Dulbecco’s phosphate buffered saline (PBS) without Ca2+ or
Mg2+  (Invitrogen),  and  containing  20  µg/ml  gentamicin
(Invitrogen), for two to three min. Each rim was trimmed, and
then the conjunctiva, endothelial layer, and iris remnants were
removed. The residual rim was sectioned into three or four
pieces. Each piece was placed with its epithelial side down
onto  a  collagen-coated  6-well  plate  (Biocoat  Collagen  I
Cellware; BD Biosciences, San Jose, CA). After a 20 to 30
min period, during which time the epithelium adhered to the
plate, a drop of keratinocyte serum-free medium (KSFM;
Invitrogen) was administered to the top of each tissue piece.
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2554Tissues  were  incubated  overnight  at  37  °C  under  95%
humidity and 5% CO2. The explants were then cultured in
KSFM  supplemented  with  50  µg/ml  of  bovine  pituitary
extract and 0.005 µg/ml of human epidermal growth factor.
The medium was replaced every two days. The tissue pieces
were removed with sterile forceps after five to seven days of
culture. When epithelial outgrowths were 70% confluent, they
were split and seeded onto coated 6-well plates at 0.5×105
cells/well. Cells were cultured in KSFM without phenol red
for  48  h,  then  removed  with  trypsin  and  processed  for
molecular biological procedures. We selected media without
phenol red for the final cell cultures because this dye has
estrogen activity [31].
Molecular biological procedures: To examine the influence
of sex on human corneal epithelial cell gene expression, total
RNA was first extracted by using TRIzol reagent. Samples
were then exposed to RNase-free DNase (Invitrogen) and
analyzed on an RNA 6000 Nano LabChip with an Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) to
verify RNA integrity. After these steps, the RNA samples
were processed using two different methods.
The first method to evaluate gene expression involved the
use of CodeLink Uniset Human 20K I Bioarrays (Amersham
Biosciences/GE Healthcare, Piscataway, NJ), which target
21,108 transcripts and 19,881 well-annotated human genes.
The RNA samples were hybridized according to reported
techniques [32]. In brief, cDNA was synthesized from RNA
(2  µg)  with  a  CodeLink  Expression  Assay  Reagent  Kit
(Amersham, Piscataway, NJ) and purified with a QIAquick
purification kit (Qiagen, Valencia, CA). After sample drying,
cRNA  was  produced  with  a  CodeLink  Expression  Assay
Reagent  Kit  (Amersham),  recovered  with  an  RNeasy  kit
(Qiagen)  and  quantified  with  a  UV  spectrophotometer.
Fragmented, biotin-labeled cRNA was then incubated and
shaken (300 rpm shaker) for 18 h on a CodeLink Bioarray at
37 °C. Following this time period, the Bioarray was washed,
exposed  to  streptavidin-Alexa  647,  and  scanned  using
ScanArray Express software and a ScanArray Express HT
scanner (Packard BioScience, Meriden, CT) with the laser set
at 635 nm, laser power at 100%, and photomultiplier tube
voltage at 60%. Scanned image files were evaluated using
CodeLink  image  and  data  analysis  software  (Amersham),
which yielded both raw and normalized hybridization signal
intensities for each array spot. The spot intensities (~20,000 )
on the microarray image were normalized to a median of one.
Standardized data, with signal intensities greater than 0.50,
were  analyzed  with  GeneSifter.Net  software  (VizX  Labs
LLC,  Seattle,  WA).  This  comprehensive  program  also
generated gene ontology and z-score reports. These ontologies
included  biological  processes,  molecular  functions  and
cellular components, and were organized according to the
guidelines of the Gene Ontology Consortium [33].
The  second  method  to  assess,  and  to  verify,  gene
expression  involved  the  use  of  Affymetrix  U133A  2.0
GeneChips (Affymetrix Inc., Santa Clara, CA), which target
18,400  transcripts  and  14,500  genes.  The  Affymetrix  and
CodeLink platforms identify 12,697 and 13,604 unique Entrez
Gene genes, respectively. Over 80% of the National Center
for Biotechnology Information (NCBI) Reference Sequence
(RefSeq)  genes  are  common  to  both  platforms.  The
Affymetrix procedure utilized the same fragmented, biotin-
labeled cRNA samples that had been prepared for CodeLink
Bioarrays. The cRNA was hybridized to GeneChips according
to the manufacturer’s protocol. Hybridized GeneChips were
then scanned with an Affymetrix Model 700 Scanner and
expression data files were generated from array images using
Affymetrix Microarray Suite 4.0 software. GeneChip data
were  normalized  by  selecting  the  default  scaling  in
Affymetrix GeneChip Operating Software, which produces a
trimmed mean intensity of 500 for each GeneChip microarray.
Standardized  data  with  a  quality  value  of  1.0  were  then
examined with GeneSifter software.
CodeLink  and  Affymetrix  gene  expression  data  were
analyzed with and without log transformation and statistical
evaluation of these data was performed with Student’s t test
(two-tailed, unpaired). Data from each platform were also
compared using the GeneSifter intersector program. The data
from the individual Bioarrays (n = 10) and GeneChips (n= 6)
are accessible for download through the National Center for
Biotechnology  Information’s  Gene  Expression  Omnibus
(GEO) via series accession number (GSE14621).
Real Time PCR procedures: The differential expression of
selected genes was verified by using quantitative real-time
PCR (qPCR) procedures. Human corneal epithelial cells from
male (n=3; 40, 62, and 79 years old) and female (n=4; 71, 73,
79, and 83 years old) donors were obtained from NDRI and
MEEI,  and  RNA  was  extracted  using  either  Trizol  or
RNAqueous Kits (Ambion, Austin, TX). The RNA samples
were evaluated with a NanoDrop spectrophotometer (Thermo
Scientific, Wilmington, DE) and a BioAnalyzer. The cDNAs
were  transcribed  by  utilizing  SuperScript  III  Reverse
Transcriptase  (Invitrogen)  and  random  hexamer  primers
(Invitrogen).  Duplex  reactions  in  triplicate  were  then
performed  by  using  TaqMan  Gene  Assays  (Applied
Biosystems,  Inc.,  Foster  City,  CA)  and  TaqMan-specific
probes for X (inactive)-specific transcript (Hs00300535_s1),
jumonji,  AT  rich  interactive  domain  1D  (Hs00190491),
carcinoembryonic antigen-related cell adhesion molecule 6
(Hs00366002),  schwannomin  interacting  protein  1
(Hs00205829),  guanine  nucleotide  binding  protein,  β14
(Hs00388871),  GTP-binding  protein  10  (putative;
Hs00414912) and β-actin endogenous control (4326315E).
Differential gene expression was calculated according to the
ΔΔCt method outline in Applied Biosystems User Bulletin
two (updated in 2001).
RESULTS
Influence of sex on overall gene expression in human corneal
epithelial cells: Sex has a significant effect on gene expression
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showed that sex influenced the expression of 661 genes, with
423 of these genes more highly expressed in females and 238
in males (Table 1). Similarly, evaluation of Affymetrix data
demonstrated  significant,  sex-related  differences  in  the
expression of 458 genes. However, with this platform, the
majority of genes were more highly expressed in males, as
compared to females (Table 1).
The reason for this apparent discrepancy appears to be
due, in large part, to differences in the lists of genes identified
as differentially expressed between the array platforms. In our
studies, 13,440 CodeLink genes and 11,026 Affymetrix genes
were  above  threshold  sensitivity  in  their  respective
microarrays. However, many of these genes were not the same
on each platform. Analysis of the Entrez Gene identifications
of  above  threshold  genes  showed  that  7,525  genes  were
identical between the platforms. Yet, 5,915 CodeLink genes
and  3,501  Affymetrix  genes  did  not  have  counterparts
expressed  above  threshold  on  the  other  platform.  And,  if
another gene identifier, such as Gene ID was used, then even
greater  differences  in  gene  expression  existed  between
platforms.
In effect, although the gene populations on the CodeLink
and Affymetrix arrays had many similarities, they also had
many dissimilarities. These variations could account for why
43% of the genes showing significant, sex-related differences
on the CodeLink Bioarray were unique to this platform, and
had  no  corresponding  transcripts  on  the  Affymetrix  array
(Table 2). Similarly, 22% of the significant Affymetrix genes
were unique, and not present in the above threshold CodeLink
genes (Table 2).
Sex-related  impact  on  specific  gene  expression  and  gene
ontologies  in  human  corneal  epithelial  cells  in  vivo:  As
anticipated, sex has a significant (p<0.05) influence on the
expression of X and Y chromosome-linked genes in human
corneal epithelial cells (Table 3). However, sex also exerts a
significant impact on many other genes. As shown in Table 4,
Table 5, and Table 6, the activity of numerous genes, such as
those encoding phosphoserine phosphatase, NF-kB2, neuritin
1, vasoactive intestinal peptide receptor 1, GalNac-T6 and
notch homolog 4 was significantly greater in corneal epithelial
cell from males. In contrast, the transcription of many other
genes,  such  as  cyclin  D1,  transglutaminase  1,
carcinoembryonic antigen-related cell adhesion molecule 6,
purinergic receptor P2X, ligand gated ion channel, 3, and β2
microglobulin was significantly higher in corneal epithelial
cells from females.
The influence of sex on gene expression in human corneal
epithelial  cells  involved  a  broad  spectrum  of  biological
processes, molecular functions and cellular components. For
example, sex altered the expression of many genes (e.g. 100
genes/category)  involved  in  activities  such  as  molecular
processes, biological regulation and catalysis (Table 7). In
addition, sex had a considerable effect on the occurrence of
specific gene ontologies. Thus, as demonstrated by z-score
analysis,  sex  had  a  significant  impact  on  the  relative
expression  of  genes  related  to  metabolic  processes,  DNA
replication,  cell  migration,  RNA  binding,  oxidoreductase
activity, nucleoli and other ontologies (Table 8 and Table 9).
Analysis of Affymetrix data also revealed that male corneal
epithelial  cells,  as  compared  to  those  of  females,  had  a
significant  increase  in  the  transcription  of  genes  (M=4↑;
F=1↓)  associated  with  the  androgen  receptor  signaling
pathway (z score=3.95), and of genes (M=7↑; F=1↓) related
to T cell activation (z score=2.80).
It is important to note that the nature of the sex-associated
influence  on  gene  ontologies  was  not  identical  on  the
CodeLink and Affymetrix platforms (Table 6, Table 7, and
Table 8). This finding was most likely due, as noted above, to
the large differences in gene expression between the array
platforms. Some molecular function and cellular component
results were similar with both arrays (Table 10). However,
almost none of the genes within the ontologies were the same,
which again reflects the differences between the platform gene
populations.
TABLE 1. INFLUENCE OF SEX ON GENE EXPRESSION IN HUMAN CORNEAL EPITHELIAL CELLS.
Genes M>F Genes F>M Total genes
CodeLink
No transformation 216 367 583
Log transformation 219 393 612
Total 238 423 661
Affymetrix
No transformation 307 118 425
Log transformation 282 114 396
Total 329 129 458
Data were analyzed with and without log transformation. The number of common and non-overlapping genes between analytical
categories was determined, and then the total numbers were calculated. The expression of listed genes was significantly (p<0.05)
influenced by sex. Abbreviations in the table are M = male and F = female.
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effect of sex on KEGG pathways in human corneal epithelial
cells. CodeLink and Affymetrix data showed that pathways
for purine and pyrimidine metabolism were both upregulated
(i.e. z scores >2.0) in males, as compared to females, but a
number of the genes were platform-specific.
To confirm in part the CodeLink and Affymetrix results,
selected genes were analyzed by qPCR. This experimental
approach  confirmed  the  sex-related  differences  in  the
expression of X (inactive)-specific transcript (F>M; up to 973
fold),  jumonji,  AT  rich  interactive  domain  1D  (M>F;
infinitely greater, because this mRNA was not detected in
female qPCR samples) and carcinoembryonic antigen-related
cell adhesion molecule 6 (F>M; up to 30 fold). The transcript
levels  of  schwannomin  interacting  protein  1,  guanine
nucleotide binding protein, β14 and GTP-binding protein 10
(putative)  were  too  low  (i.e.  average  thresholds  typically
TABLE 2. SIGNIFICANT, SEX-RELATED DIFFERENCES IN GENE EXPRESSION: COMPARISONS BETWEEN CODELINK AND AFFYMETRIX ARRAYS.
Genes
M>F
Genes
F>M
Total
genes
CodeLink
Number of genes with significant differences in expression 216 367 583
Number of genes with same results on Affymetrix 22 20 42
Number of genes changed in same direction on Affymetrix 82 133 215
Number of genes changed in opposite direction on Affymetrix 10 58 68
Number of genes with opposite results on Affymetrix 0 4 4
Number of unique genes, not expressed by Affymetrix 102 152 254
Affymetrix
Number of genes with significant differences in expression 307 118 425
Number of genes with same results on CodeLink 22 20 42
Number of genes changed in same direction on CodeLink 141 69 210
Number of genes changed in opposite direction on CodeLink 66 8 74
Number of genes with opposite results on CodeLink 4 0 4
Number of unique genes, not expressed by CodeLink 74 21 95
Data were analyzed without log transformation. The phrase “Number of genes with same (or opposite) results” means that the
findings were significant (p<0.05) on both platforms. The term “Number of genes changed in same (or opposite) direction”
means that results were significant on one platform, but not on the other. The phrase “same direction” was also used for a gene
demonstrating significant up- or down-regulation on one platform and a corresponding, but not significant, alteration in at least
one gene transcript on the other array (note: some genes had several transcripts). Genes labeled as “unique” were not expressed
at above threshold levels on the other array platform.
TABLE 3. SEX-RELATED EXPRESSION OF X AND Y CHROMOSOME GENES IN HUMAN CORNEAL EPITHELIAL CELLS.
Entrez gene identification Gene CL ratio Affy ratio CL p value Affy p value Ontology
Male>Female
Y chromosome
6192 Ribosomal protein S4 314.1 1289.3 <0.0000 <0.0001 translation
8287 Ubiquitin specific peptidase 9 54.4 110.0 <0.0241 <0.0103 ubiquitin cycle
8284 Jumonji, AT rich interactive domain
1D
33.7 64.8 <0.0000 <0.0004 chromatin modification
9086 Eukaryotic translation initiation factor
1A
12.4 27.5 <0.0039 <0.0023 translational initiation
8653 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 3
4.8 197.3 <0.0139 <0.0002 nucleotide binding
Female>Male
X chromosome
7503 X (inactive)-specific transcript 248.7 373.7 <0.0003 <0.0136 inactivation of X
chromosome
1964 Eukaryotic translation initiation factor
1A, X-linked
1.8 1.5 <0.0479 <0.0177 translational initiation
7403 Ubiquitously transcribed
tetratricopeptide repeat
1.7 1.7 <0.0085 <0.0001 binding
Relative ratios were calculated by comparing the degree of gene expression in corneal epithelial cells from men and women.
Abbreviations in the table are CL = CodeLink; Affy = Affymetrix.
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2560exceeded  31  cycles)  to  reliably  quantitate  with  qPCR
procedures.
Sex-related  impact  on  specific  gene  expression  and  gene
ontologies  in  human  corneal  epithelial  cells  in  vitro:  To
determine whether sex-related differences in gene expression
are maintained in cultured human corneal epithelial cells, cells
were cultured as described in the Methods and then processed
for  molecular  biological  procedures  and  analysis  with
CodeLink Bioarrays.
Our results show that sex-associated differences exist in
the expression of 437 genes, with 220 genes more highly
expressed in females and 217 in males. These genes are linked
to X and Y chromosomes (Table 11), as well as to autosomes
that  encode  such  proteins  as  small  proline-rich  protein  3,
defensin  β1,  lipocalin  2  and  Sjögren  syndrome  nuclear
autoantigen 1 (Table 12). The nature of these sex differences
encompassed genes involved in cell growth, wound response,
tyrosine kinase signaling and chromatin modification (Table
13). The majority of these genes were different than those
identified in the non-cultured corneal epithelial cells.
If data from cultured and noncultured human corneal
epithelial cells were combined, then significant, sex-related
differences  were  identified  in  255  genes  (M>F=84;
F>M=171).  These  genes  included  those  encoding  retinol
dehydrogenase  8,  retinoid  X  receptor α,  α 1,4
galactosyltransferase and the estrogen receptor 1 (Table 14).
DISCUSSION
The present study demonstrates that sex has a significant
influence  on  the  expression  of  over  600  genes  in  human
corneal epithelial cells in vivo. These genes are associated
with  a  broad  array  of  biological  processes,  molecular
functions and cellular components, including such activities
as metabolic processes, DNA replication, cell migration, RNA
binding, oxidoreductase activity and nucleoli. These results
support our hypothesis that fundamental variations in gene
expression may contribute to the sex-associated differences in
the anatomy, physiology and pathophysiology of the human
cornea.
However,  the  precise  nature  of  these  sex-related
differences  in  gene  expression,  as  identified  with  the
CodeLink  Bioarrays  and  Affymetrix  GeneChips,  varied
depending upon the microarray platform. Originally, we had
chosen to run CodeLink Bioarrays to evaluate the influence
of sex on human corneal epithelial cell gene expression, and
to confirm possible significant differences by using a separate
platform, the Affymetrix GeneChip. We found, though, that
there  were  tremendous  differences  in  gene  populations
between the array platforms, such that over 5,900 CodeLink
genes  and  more  than  3,500  Affymetrix  genes  had  no
counterparts expressed above threshold on the other platform.
Indeed, 43% of the genes showing significant, sex-related
differences on the CodeLink Bioarray were unique to this
platform,  and  had  no  corresponding  transcripts  on  the
TABLE 7. INFLUENCE OF SEX ON THE EXPRESSION OF HUMAN CORNEAL GENES RELATED TO BIOLOGICAL PROCESSES, MOLECULAR
FUNCTIONS AND CELLULAR COMPONENTS.
Ontologies Array Total genes Male>Female Female>Male
Biological process ontologies
cellular process CL 346 121 225
Affy 267 195 72
metabolic process CL 244 83 161
Affy 207 143 64
biological regulation CL 186 60 126
Affy 160 119 41
Molecular Function ontologies
binding CL 342 127 215
Affy 279 204 75
catalytic activity CL 171 70 101
Affy 128 90 38
Cellular component ontologies
cell CL 396 148 248
Affy 311 221 90
organelle CL 266 99 167
Affy 224 154 70
All genes displayed significant (p<0.05) differences in sex-related expression. Results are shown for selected ontologies
containing at least 100 genes on both array platforms. Abbreviations in the table are CL = CodeLink; Affy = Affymetrix.
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2561Affymetrix GeneChip. Similarly, over 20% of the significant
Affymetrix genes were unique to this platform. Given these
differences in gene populations, it is not surprising that the
lists of sex-associated differentially expressed genes and gene
ontologies were not identical on the CodeLink and Affymetrix
platforms.
A question, then, is whether these platform-specific data
have any biological meaning. The answer, based upon recent
studies, is yes. A number of investigations have found that
significant  differences  exist  between  CodeLink  and
Affymetrix platforms in their ability to detect differential gene
expression [34-36]. These studies have also reported little
agreement between these platforms concerning the lists of the
differentially expressed genes [34-37]. Even if exactly the
same sequences and genes are compared, there is only 60 to
70% overlap in CodeLink and Affymetrix data [38]. This low
concordance  in  gene  identification  appears  to  be  due  to
intrinsic differences in platform design, including variations
in probe length and content, deposition technology, labeling
approaches,  hybridizing  protocols,  image  segmentation,
signal detection, background correction, data normalization
and  data  mining  [34-36,38],  combined  with  the  intrinsic
instability of lists of significantly changed genes based on p-
value  cut-offs  [39].  The  result  is  that  CodeLink  and
Affymetrix arrays, both of which have proven reproducibility
and  accuracy,  seem  to  measure  different  things  [36].
However, the majority of gene expression changes revealed
by  each  of  the  platforms  are  believed  to  be  biologically
correct,  and  these  differences  cannot  be  attributed  to
technological variations [34,35]. It has also been suggested
that for a more meaningful transcriptome assessment, one may
have to analyze the same sample with different microarray
platforms [35]. The genes contained in the intersection of the
two lists can be used as reliable biomarkers, while the genes
in the union can be used to identify biological pathways.
Given this information, the CodeLink and Affymetrix
microarray data concerning sex-related differences in gene
expression of human corneal epithelial cells are biologically
relevant. However, since these arrays do not evaluate the same
gene  populations,  the  results  should  be  different.  Such
TABLE 8. EFFECT OF SEX ON THE EXPRESSION OF GENE ONTOLOGIES IN HUMAN CORNEAL EPITHELIAL CELLS, AS SHOWN WITH CODELINK BIOARRAYS.
Ontology M Genes ↑ F Genes ↑ M z-score F z-score
Biological process
hexose metabolic process 6 4 3.5 0.67
DNA replication 6 5 2.47 0.45
regulation of cellular metabolic process 16 48 -2.03 0.52
RNA metabolic process 16 53 -2.4 0.74
monocarboxylic acid metabolic process 5 10 1.42 2.4
fatty acid metabolic process 4 8 1.38 2.31
Molecular function
actin binding 9 4 3.52 -0.62
calcium ion binding 16 11 2.48 -1.31
iron ion binding 7 6 2.48 0.37
oxidoreductase activity 14 16 2.41 0.65
transcription factor activity 3 15 -2.05 -0.28
ligase activity 7 13 1.6 2.3
Cellular component
nucleolus 5 7 2.22 2.21
intracellular 107 193 0.08 2.87
nucleus 42 95 -0.88 2.64
mitochondrial part 6 17 0.04 2.48
extracellular region 19 17 0.38 -2.28
integral to membrane 48 58 0.26 -2.4
A z-score is a statistical measure of the relative expression of gene ontologies, and shows how much each ontology is over- or
under-represented in a gene list. More specifically, the z-score is a standardized difference using the expected value and standard
deviation of the number of genes meeting the criterion of a gene ontology term under a hypergeometric distribution [89]. Positive
z scores indicate gene ontology terms with a greater number of genes meeting the criterion than is expected by chance, whereas
negative z scores reflect gene ontology terms with fewer genes meeting the criterion than expected by chance. A z score near
zero suggests that the number of genes meeting the criterion approximates the expected number [89]. Selected z-scores with
values >2.0 or less than <-2.0 are reported for ontologies with ≥10 genes. Data were analyzed without transformation. In the
table, the terms are: M Genes ↑ - number of genes up-regulated in human corneal epithelial cells of males (M), as compared to
those of females (F); F Genes ↑ - number of genes up-regulated in human corneal epithelial cells of females, as compared to
those of males; z-score - specific score for the up-regulated genes in the male and female cells.
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2562platform-dependent differences in experimental outcomes are
thought  to  be  prominent  in  biological  systems  where  the
magnitude  of  differences  between  the  two  samples  is
relatively low [35].
Our microarray analyses showed that numerous genes
were expressed to a significantly greater extent in corneal
epithelial cells of men, as compared to women. These included
a  variety  of  genes  associated  with  signal  transduction
pathways, such as CD47 (binds thrombospondin), jagged 2
(activates  Notch  receptors),  vasoactive  intestinal  peptide
receptor 1 and G protein coupled estrogen receptor 1 (binds
estrogen and promotes nongenomic signaling events). Males
also  expressed  higher  activities  of  genes  promoting  cell
adhesion (cell adhesion molecule 1 and claudin 16), elastin
deposition in the extracellular matrix (lysyl oxidase-like 1),
mucin-type O-linked glycosylation (UDP-N-acetyl-alpha-D-
- N   e d i t p e p y l o p : e n i m a s o t c a l a g
acetylgalactosaminyltransferase  6),  thyroid  hormone
inactivation  (Type  III  iodothyronine  deiodinase),
lysophospholipid  hydrolysis  (ectonucleotide
pyrophosphatase/ phosphodiesterase 2) and neurite outgrowth
and arborization (neuritin 1).
Of particular interest were the increased expression in
males of corneal genes encoding: a) selenium-binding protein
1, a retinal antigen that may contribute to the pathogenesis of
uveitis in patients with Behcet’s disease [40]; b) citron, a dual
specificity protein kinase that plays an important role in the
regulation of cytokinesis [41]. It is possible that activity of this
protein may contribute to the greater mitotic index found in
the corneal epithelium of male mice (2); c) epidermal growth
factor  receptor,  which  stimulates  corneal  epithelial  cell
proliferation and wound healing [42]. A significant increase
in epidermal growth factor receptor levels are also found in
peripheral tissues of males, as compared to females [43]; and
d) thymidylate synthetase, an enzyme that promotes DNA
synthesis and repair [41].
These latter sex-related effects are especially intriguing,
given that males have a significantly higher expression of
corneal epithelial cell genes associated with DNA replication
and cell migration. These sex-associated influences may be
due to the influence of androgens. The reason is that androgens
have been reported to repair defects, promote wound healing
and stimulate mitosis in the corneal epithelium, as well as to
suppress angiogenesis and correct dystrophies in the cornea
[2,44-47].  Indeed,  a  Brazilian  pharmaceutical  firm  has
marketed  topical  androgens  to  treat  corneal  trauma,
cicatrization,  erosions,  ulcers  and  atrophy,  as  well  as  to
facilitate post-operative care after corneal transplantation.
In contrast, females had greater expression of many other
genes, including those related to pain responses (purinergic
receptor P2X, ligand gated ion channel, 3), neural signaling
(γ-aminobutyric acid A receptor β3), cell cycle (cyclin D1),
arachidonic acid hydroxylation (cytochrome P450, family 4,
subfamily F, polypeptide 12), cysteine protease inhibition
(calpastatin), prolactin regulation (paired-like homeodomain
1) and a variety of cellular processes associated with G protein
signaling (GTP-binding protein 10).
TABLE 9. INFLUENCE OF SEX ON THE EXPRESSION OF GENE ONTOLOGIES IN HUMAN CORNEAL EPITHELIAL CELLS, AS SHOWN WITH AFFYMETRIX ARRAYS.
Ontology M Genes ↑ F Genes ↑ M z-score F z-score
Biological process
macromolecular complex assembly 23 11 4.36 3.92
cell motility 14 3 2.53 0.15
cell migration 9 2 2.29 0.29
response to stress 11 7 -2.02 -0.11
ribonucleoprotein complex biogenesis and assembly 5 6 0.74 4.02
metabolic process 144 63 1.58 2.97
transcription from RNA polymerase II promoter 15 10 0.75 2.54
Molecular function
transcription activator activity 12 4 2.69 1.19
protein binding 139 51 2.49 0.8
RNA binding 20 10 2.38 2.5
transmembrane receptor activity 8 2 -2.01 -1.73
transcription coactivator activity 8 4 2.34 2.18
receptor activity 17 3 -1.54 -2.23
Cellular component
actin cytoskeleton 11 2 3.32 0.27
nucleoplasm part 14 8 2.43 3.05
cytoplasmic membrane-bound vesicle 11 5 2.21 1.87
intracellular organelle part 69 37 1.99 3.78
Golgi membrane 9 7 1.53 3.4
extracellular region 20 4 -1.59 -2.2
Selected z-scores with values >2.0 or less than <-2.0 are listed for ontologies with ≥10 genes. Terminology and abbreviation
explanations are presented in the legend to Table 8.
Molecular Vision 2009; 15:2554-2569 <http://www.molvis.org/molvis/v15/a274> © 2009 Molecular Vision
2563Several other sex-related differences in gene expression
were quite notable. Females had a lower expression of genes
encoding  phosphoserine  phosphatase,  an  enzyme  that
catalyzes L-serine formation. Deficiency of this protein has
been linked to Williams syndrome [48], which often presents
with  hyperopia  [49].  Women,  in  turn,  are  more  likely  to
develop hyperopia [50,51]. Women had a higher expression
of the genes encoding: a) carcinoembryonic antigen-related
cell adhesion molecule 6, a protein often increased in cancer
[41]; b) X (inactive)-specific transcript, which is expressed
exclusively from the X inactivation center of the inactive X
chromosome [41], and interestingly may be downregulated by
desiccation stress [52]; and c) transglutaminase 1, enzyme that
catalyzes protein cross-linking. This expression of this protein
is typically increased in dry eye and corneal keratinization
[53,54].
We  wonder  if  this  increased  expression  of
transglutaminase 1 may contribute to the increased prevalence
of dry eye in women [55]. We also wonder whether this
heightened  expression  may  be  due  to  the  influence  of
estrogens, given that these hormones are known to increase
the  levels  of  various  transglutaminases  in  other  tissues
[56-58]. If so, then estrogen could potentially promote corneal
abnormalities and dry eye. Consistent with this hypothesis is
the finding that estrogen administration is associated with a
significant increase in the signs and symptoms of dry eye
[59,60]. Indeed, estrogen treatment has been linked to the
induction  of  photophobia,  blurred  vision,  foreign  body
sensation, heightened sensitivity, contact lens intolerance and
variations in corneal thickness, edema and curvature [19,26,
27,29,61-65]. These effects may account for why hormone
replacement therapy in postmenopausal women may reduce
visual acuity [66], and why oral contraceptive use in pre-
menopausal  women  may  increase  corneal  hydration,
sensitivity and contact lens discomfort [27,67,68], and lead to
an elevated blink rate [69].
If androgens and estrogens do mediate some of the sex-
related  differences  in  gene  expression  in  human  corneal
epithelial cells, then the mechanism by which sex steroids act
most likely involves the local, intracrine synthesis of these
hormones  from  adrenal  sex  steroid  precursors  and  a
consequent hormone association with saturable, high-affinity
and steroid-specific receptors. Classically, the monomeric,
activated  steroid-receptor  complex  would  then  bind  to  a
response element(s) in the regulatory region of specific target
genes, dimerize with another steroid-bound complex and, in
combination  with  appropriate  co-activators,  regulate  gene
transcription [70,71]. In support of this hypothesis, we and
TABLE 10. IMPACT OF SEX ON THE EXPRESSION OF GENE ONTOLOGIES IN HUMAN CORNEAL EPITHELIAL CELLS, AS SHOWN WITH BOTH CODELINK AND AFFYMETRIX
ARRAYS.
Ontology Array M Genes ↑ F Genes ↑ M z-score F z-score
Molecular function
small conjugating protein ligase activity CL 5 4 2.77 0.71
Affy 6 2 2.35 1.09
acid-amino acid ligase activity CL 5 4 2.5 0.49
Affy 6 2 2.06 0.94
cytoskeletal protein binding CL 10 6 2.76 -0.69
Affy 13 3 2.18 0.09
transcription coactivator activity CL 5 5 2.1 0.7
Affy 8 4 2.34 2.18
Cellular component
nuclear body CL 1 8 -0.24 4.21
Affy 4 4 1.43 3.69
nucleus CL 42 95 -0.88 2.64
Affy 84 37 1.75 2.11
intracellular CL 107 193 0.08 2.87
Affy 174 76 2.11 3.31
intracellular part CL 103 184 0.16 2.57
Affy 168 75 2.07 3.53
intracellular organelle CL 85 153 0.08 2.11
Affy 142 63 1.98 2.95
intracellular membrane-bound organelle CL 74 139 -0.21 2.21
Affy 127 56 1.89 2.63
membrane-bound organelle CL 74 139 -0.22 2.2
Affy 127 56 1.88 2.62
organelle CL 85 153 0.07 2.1
Affy 142 63 1.97 2.94
extracellular region CL 19 17 0.38 -2.28
Affy 20 4 -1.59 -2.2
Selected z-scores with values >2.0 or less than <-2.0 are reported. Terminology and abbreviation explanations are presented in
the legend to Table 8. In the table, abbreviations are: CL = CodeLink; Affy = Affymetrix.
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2564others have shown that the cornea contains the enzymatic
machinery  necessary  for  the  intracrine  synthesis  and
metabolism of androgens and estrogens [72-74]. Moreover,
we and others have shown that the cornea contains androgen
and  estrogen  receptors  [75-78]  and  that  sex  steroids  may
regulate gene expression in primary and immortalized human
corneal  epithelial  cells  [79,80]  (Dr.  Payal  Khandelwal,
personal communication).
Our  current  investigation  also  demonstrates  that  sex
exerts  a  significant  impact  on  gene  expression  in  human
corneal epithelial cells in vitro. However, with few exceptions
(e.g. X- and Y-linked genes), these sex-related differences in
gene expression in vitro were typically different than those in
vivo. There are several possible explanations for this finding.
First, the influence of sex steroids on gene expression is lost
during culture. Second, the molecular biological effects of
hormones  from  the  hypothalamic-pituitary  axis,  which  is
differentially regulated by sex steroids, are also absent during
cell culture. Loss of this axis’ hormonal impact has been
shown to underlie the striking differences in gene expression
between other cell types in vivo and in vitro [81,82].
Additional explanations for the sex-related differences in
gene expression in vivo and/or in vitro include the effects of
Y-linked  genes  in  males  [83],  and  of  X  inactivation  and
associated  X  escapees  in  females.  X  inactivation  is  a
chromosome-wide  silencing  mechanism  that  evolved  to
restore equal gene expression between males and females.
However, although the process of X inactivation silences a
majority of genes, 100 to 200 genes may escape this silencing
and  be  expressed  from  both  X  chromosomes  in  females
[83-86].  There  are  also  a  number  of  other  hormone-
independent mechanisms that may account for genes that are
TABLE 11. SEX-RELATED EXPRESSION OF X AND Y CHROMOSOME GENES IN HUMAN CORNEAL EPITHELIAL CELLS IN VITRO.
Entrez gene identification Gene Ratio p value Ontology
Male>Female
Y chromosome
6192 Ribosomal protein S4, Y-linked 1 349.1 <0.009
0
translation
8287 Ubiquitin specific peptidase 9, Y-linked (fat facets-like,
Drosophila)
165.0 <0.021
2
ubiquitin-dependent protein catabolic process
8653 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked 27.4 <0.011
7
nucleotide binding
9086 Eukaryotic translation initiation factor 1A, Y-linked 20.6 <0.001
8
translational initiation
8284 Jumonji, AT rich interactive domain 1D 16.5 <0.005
0
spermatogenesis
22829 Neuroligin 4, Y-linked 8.3 <0.028
2
cell adhesion
84663 Chromosome Y open reading frame 15B 4.3 <0.002
0
Female>Male
X chromosome
7503 X (inactive)-specific transcript 348.4 <0.000
0
inactivation of X chromosome
9643 Mortality factor 4 like 2 3.0 <0.038
5
regulation of cell growth
Relative ratios were calculated by comparing the degree of sex-related gene expression in corneal epithelial cells that had been
cultured in vitro. Data were analyzed with and without log transformation.
TABLE 12. SEX-ASSOCIATED DIFFERENCES IN GENE EXPRESSION IN HUMAN CORNEAL EPITHELIAL CELLS IN VITRO.
Entrez gene identification Gene Ratio p value Ontology
Male>Female
3105 Major histocompatibility complex, class I, A 154.0 <0.0048 antigen processing and presentation of
peptide antigen via MHC class I
6707 Small proline-rich protein 3 4.3 <0.0316 epidermis development
1672 Defensin β1 3.3 <0.000 chemotaxis
3934 Lipocalin 2 (oncogene 24p3) 3.0 <0.0193 transport
23705 Cell adhesion molecule 1 2.3 <0.0290 T cell mediated cytotoxicity
Female>Male
* CDNA FLJ40891 fis, clone UTERU2001110 10.0 <0.0091
822 Capping protein (actin filament), gelsolin-like 2.9 <0.0124 protein complex assembly
284217 Laminin α1 2.1 <0.0045 multicellular organismal development
2559 Gamma-aminobutyric acid (GABA) A receptor α6 2.1 <0.0467 ion transport
8636 Sjogren syndrome nuclear autoantigen 1 1.6 <0.0148 identical protein binding
Data were analyzed with and without log transformation. The asterisk indicates gene accession number = BQ068355
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2565expressed  in  a  sex-specific  (i.e.  exclusively  in  males  or
females) or a sex-biased (i.e. higher level in either males or
females) manner [87,88]. The number of sex-biased genes
appear to be considerable, although fold-differences in gene
expression,  at  least  in  somatic  tissues  (e.g.  liver,  muscle,
adipose tissue, brain), tend to be modest (e.g. <1.2 fold) [88].
Overall, our findings support our hypothesis that sex-
related differences exist in the gene expression of human
corneal epithelial cells. Further studies are required to explore
how these variations in gene expression may contribute to sex-
related  differences  in  the  prevalence  of  certain  corneal
diseases.
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TABLE 13. EFFECT OF SEX ON THE EXPRESSION OF GENE ONTOLOGIES IN HUMAN CORNEAL EPITHELIAL CELLS IN VITRO.
Ontology M Genes ↑ F Genes ↑ M z-score F z-score
Biological process
regulation of cell morphogenesis 8 4 3.32 1.1
regulation of cell growth 6 4 3.27 2.02
response to wounding 9 4 2.07 -0.04
transmembrane receptor protein tyrosine kinase signaling pathway 4 6 1.36 3.14
chromatin modification 4 6 1.13 2.83
response to stimulus 28 12 1.03 -2.09
intracellular signaling cascade 17 6 0.55 -2.1
Molecular function
carbohydrate binding 10 4 4.18 0.8
heparin binding 4 2 3.37 1.34
UDP-glycosyltransferase activity 4 1 2.62 -0.09
glycosaminoglycan binding 4 2 2.78 0.98
calcium ion binding 16 4 2.31 -1.61
phosphoprotein phosphatase activity 0 5 -1.29 2.88
anion transmembrane transporter activity 2 4 0.52 2.43
protein binding 79 82 0.59 2.16
Cellular component
Golgi membrane 11 2 3.91 -0.86
cytoplasmic vesicle membrane 4 2 2.83 0.91
cytoplasm 78 74 2.15 1.64
cytosol 6 11 0.63 3.05
centrosome 4 4 2.06 2.09
Selected z-scores with values >2.0 or less than <-2.0 are shown for selected ontologies with ≥5 genes. Terminology and
abbreviation explanations are presented in the legend to Table 8.
TABLE 14. SEX-RELATED DIFFERENCES IN GENE EXPRESSION IN HUMAN CORNEAL EPITHELIAL CELLS IN VIVO AND IN VITRO.
Entrez gene identification Gene Ratio p value Ontology
Male>Female
8793 Tumor necrosis factor receptor superfamily, member
10d, decoy with truncated death domain
1.9 <0.0066 apoptosis
1735 Deiodinase, iodothyronine, type III 1.5 <0.0154 thyroid hormone catabolic process
154091 Solute carrier family 2 (facilitated glucose
transporter), member 12
1.5 <0.0085 carbohydrate transport
3931 Lecithin-cholesterol acyltransferase 1.6 <0.0460 lipid metabolic process
50700 Retinol dehydrogenase 8 (all-trans) 1.4 <0.0472 estrogen biosynthetic process
Female>Male
26354 Guanine nucleotide binding protein-like 3 (nucleolar) 2.1 <0.0225 regulation of cell proliferation
51552 RAB14, member RAS oncogene family 1.9 <0.0459 Golgi to endosome transport
53947 α 1,4-galactosyltransferase (globotriaosylceramide
synthase)
1.9 <0.0282 glycosphingolipid biosynthetic process
6256 Retinoid X receptor α 1.8 <0.0499 transcription
2099 Estrogen receptor 1 1.7 <0.0102 transcription
Data were analyzed without log transformation.
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